Trial Profile
OC 000459 in patients with eosinophilc oesophagitis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Oct 2013
Price :
$35
*
At a glance
- Drugs Timapiprant (Primary)
- Indications Eosinophilic oesophagitis
- Focus Biomarker; Therapeutic Use
- 16 Oct 2013 Results presented at the 21st United European Gastroenterology Week.
- 26 May 2012 New trial record
- 22 May 2012 Results presented at Digestive Disease Week 2012.